Tirzepatide lowered risk of worsening heart failure and CVD death for obese adults
In an international trial of 713 adults in nine countries including the U.S. called SUMMIT, participants with heart failure ...
Armed robbery in Revesby19h
Tirzepatide Cuts Heart Failure, CVD Death Risk
In an international trial of 713 adults in nine countries including the U.S. called SUMMIT, participants with heart failure with ...
The American Journal of Managed Care19h
For Obesity and HFpEF, Tirzepatide Cuts Risk of CV Death or Worsening HF by 38%
Payers and employers have tightened access to the glucagon-like peptide-1 receptor agonist class once these therapies became ...